Table 5.
Marker levels and clinical characteristics of patients with endometriosis (n = 47).
| Variable | N (%) | Urinary enolase 1 ng/mL | Enolase-Cr (ng/mg Cr) | CA125 (IU/mL) | CA19-9 (IU/mL) | |
|---|---|---|---|---|---|---|
| Mean ± SD | ||||||
| Age (years) | <30 | 17 (36.2) | 1672 ± 467 | 19 ± 6.5 | 129.3 ± 33.3 | 34.2 ± 10 |
| 30–39 | 20 (42.6) | 1668 ± 288 | 12.8 ± 3.2 | 129.8 ± 35.4 | 27.4 ± 8.4 | |
| ≥40 | 10 (21.3) | 2585 ± 626 | 14 ± 2.6 | 62.7 ± 20.9 | 18.8 ± 6.5 | |
| p value | — | 0.610∗ | 0.567∗ | 0.378∗ | 0.509∗ | |
| BMI (kg/m2) | <24.9 | 20 (42.6) | 2125 ± 454 | 15.69 ± 5.5 | 114 ± 27.9 | 39.8 ± 9.9 |
| ≥24.9 | 27 (57.4) | 1672 ± 272 | 15.11 ± 2.6 | 116 ± 28.1 | 19.3 ± 5 | |
| p value | — | 0.493∗∗ | 0.345∗∗ | 0.420∗∗ | 0.176∗∗ | |
| Stage of endometriosis | Stage I + II | 8 (17) | 1727 ± 943 | 11.47 ± 6.2 | 104.8 ± 42.4 | 15.9 ± 9 |
| Stage III + IV | 39 (83) | 1933 ± 254 | 16.16 ± 3.1 | 117.5 ± 22.5 | 30.5 ± 6 | |
| p value | — | 0.819∗∗ | 0.575∗∗ | 0.795∗∗ | 0.274∗∗ | |
| CA125 (35 U/mL) | ≤35 | 14 (29.8) | 1948 ± 553 | 16 ± 4.4 | — | 5.46 ± 0.98 |
| >35 | 33 (70.2) | 1814 ± 269 | 15 ± 3.5 | — | 34.27 ± 11.3 | |
| p value | — | 0.567∗∗ | 0.378∗∗ | — | <0.001∗∗ | |
| Menstrual phase | Follicular phase | 29 (61.7) | 1430 ± 207 | 11.3 ± 2.5 | 135.7 ± 29.2 | 28.1 ± 5.9 |
| Luteal phase | 18 (38.3) | 2565 ± 523 | 21.8 ± 5.8 | 82.6 ± 20.3 | 28 ± 10.1 | |
| p value | — | 0.017∗∗ | 0.039∗∗ | 0.091∗∗ | 0.712∗∗ | |
| Infertility | Yes | 19 (40.4) | 2101 ± 420 | 16.9 ± 3.8 | 93.2 ± 19.1 | 26.2 ± 7.6 |
| No | 28 (59.6) | 1704 ± 305 | 14.3 ± 3.9 | 130 ± 30.7 | 29.3 ± 7.3 | |
| p value | — | 0.480∗∗ | 0.503∗∗ | 0.422∗∗ | 0.885∗∗ | |
∗Results of the ANOVA test; ∗∗results of the Mann-Whitney U test.